CAS 6646-46-4

Imidazo[2,1-b]thiazole,6-(4-bromophenyl)-2,3,5,6-tetrahydro-

Description:

Imidazo[2,1-b]thiazole, 6-(4-bromophenyl)-2,3,5,6-tetrahydro- is a heterocyclic compound characterized by its fused imidazole and thiazole rings, which contribute to its unique chemical properties. This compound features a tetrahydro structure, indicating the presence of a saturated cyclic system, and a bromophenyl substituent that enhances its reactivity and potential biological activity. The presence of the bromine atom introduces significant electronegativity, which can influence the compound's interactions with biological targets. Imidazo[2,1-b]thiazoles are often studied for their pharmacological properties, including antimicrobial and anticancer activities. The compound's molecular structure allows for various functionalization possibilities, making it a candidate for further chemical modifications. Its solubility, stability, and reactivity can vary depending on the solvent and environmental conditions, which are important considerations in both synthetic and application contexts. Overall, this compound exemplifies the diverse chemistry of heterocycles and their potential utility in medicinal chemistry and material science.

Formula: C₁₁H₁₁BrN₂S

Synonyms:

• Imidazo[2,1-b]thiazole,6-(p-bromophenyl)-2,3,5,6-tetrahydro- (7CI,8CI)
• (?à)-p-Bromotetramisole
• 4-Bromotetramisole

6-(4-Bromophenyl)-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole

CAS: 6646-46-4

6-(4-Bromophenyl)-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole is a phosphatase inhibitor. It is used to treat hyperphosphatemia in patients with end-stage renal disease who are on dialysis. 6-(4-Bromophenyl)-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole inhibits the activity of tyrosine phosphatases and prevents the uptake of calcium and phosphate from the gastrointestinal tract. This drug has been shown to improve bone mineralization in postmenopausal women with osteoporosis.

Formula: C₁₁H₁₁BrN₂S

Purity: Min. 95%

Molecular weight: 283.19 g/mol

Ref: 3D-GAA64646